Signal Processing in Magnetic Resonance Spectroscopy with Biomedical Applications
Language: English
Published by CRC Pr I Llc, 2009
- Hardcover
- New

Seller: Revaluation Books, Exeter, United KingdomRevaluation Books
AbeBooks seller since January 6, 2003
Condition: New
US$ 338.23
Quantity: 1 available
Add to basketItem description from seller
1st edition. 432 pages. 9.57x6.42x1.06 inches. In Stock.
Seller Inventory # __1439806446
- Title
- Signal Processing in Magnetic Resonance Spectroscopy with Biomedical Applications
- Author
- Belkic, Dzevad (Author)/ Belkic, Karen (Author)
- Publisher
- CRC Pr I Llc
- Publication year
- 2009
- Condition
- Brand New
- Binding
- Hardcover
- Language
- English
- ISBN 10
- 1439806446
- ISBN 13
- 9781439806449
- Item weight
- 0.8 kilograms
Uses the FPT to Solve the Quantification Problem in MRS
An invaluable tool in non-invasive clinical oncology diagnostics
Addressing the critical need in clinical oncology for robust and stable signal processing in magnetic resonance spectroscopy (MRS), Signal Processing in Magnetic Resonance Spectroscopy with Biomedical Applications explores cutting-edge theory-based innovations for obtaining reliable quantitative information from MR signals for cancer diagnostics. By defining the natural framework of signal processing using the well-established theory of quantum physics, the book illustrates how advances in signal processing can optimize MRS.
The authors employ the fast Padé transform (FPT) as the unique polynomial quotient for the spectral analysis of MR time signals. They prove that residual spectra are necessary but not sufficient criteria to estimate the error invoked in quantification. Instead, they provide a more comprehensive strategy that monitors constancy of spectral parameters as one of the most reliable signatures of stability and robustness of quantification. The authors also use Froissart doublets to unequivocally distinguish between genuine and spurious resonances in both noise-free and noise-corrupted time signals, enabling the exact reconstruction of all the genuine spectral parameters. They show how the FPT resolves and quantifies tightly overlapped resonances that are abundantly seen in MR spectra generated using data from encoded time signals from the brain, breast, ovary, and prostate.
Written by a mathematical physicist and a clinical scientist, this book captures the multidisciplinary nature of biomedicine. It examines the remarkable ability of the FPT to unambiguously quantify isolated, tightly overlapped, and nearly confluent resonances.
"Synopsis" may belong to another edition of this title.
About the Author
Dževad Belkić is a professor of mathematical radiation physics at the Karolinska Institute in Stockholm, Sweden. Dr. Belkić’s current research activities encompass atomic collision physics, radiation physics, radiobiology, magnetic resonance physics and mathematical physics.
Karen Belkić is a physician specialist in internal medicine, adjunct professor of preventive medicine at the Keck School of Medicine of the University of Southern California in Los Angeles, and senior scientist in the oncology and pathology department at the Karolinska Institute in Stockholm, Sweden.
"About the title" may belong to another edition of this title.
Revaluation Books
Exeter, United Kingdom
AbeBooks seller since January 6, 2003
Shipping rates from United Kingdom to U.S.A.
| Item | 7 to 14 business days | 2 to 3 business days |
|---|---|---|
| First item | US$ 16.57 | US$ 39.76 |
Payment methods
Seller's business information
Edward Bowditch Ltd
Exstowe, Exton
Exeter, United Kingdom EX3 0PP
Terms of sale
Legal entity name: Edward Bowditch Ltd
Legal entity form: Limited company
Business correspondence address: Exstowe, Exton, Exeter, EX3 0PP
Company registration number: 04916632
VAT registration: GB834241546
Authorised representative: Mr. E. Bowditch
Shipping terms
Orders usually dispatched within two working days. Please note that at this time all domestic United Kingdom orders are sent by trackable UPS courier, we choose not to offer a lower cost alternative.